Event Calendar

Tuesday, May 11, 2021

ICNC Test

Start Date: 5/9/2021 8:00 AM EDT
End Date: 5/11/2021 5:00 PM EDT

Location:
United States 

Overview: This webinar will provide an update of best practices and specific case examples associated with the interpretation and reporting of Tc99m-PYP for evaluation of patients suspected of having ATTR Cardiac Amyloidosis (ATTR-CA). This program will feature Drs. Jamieson Bourque, Edward Miller, Brett Sperry, and Saurabh Malhotra.

Registration

  • Free for ASNC members!
  • $75 for Nonmembers
Not yet and ASNC member? Join ASNC today.

Moderator: Jamieson Bourque, MD, MHS, FASNC
1.    Introduction and Update on the Multimodality Imaging Expert Consensus Recommendations Jamieson Bourque, MD, MHS, FASNC
2.    Cases and associated practical points in interpretation and reporting – Jamieson Bourque, MD, MHS, FASNC, Edward Miller, MD, PhD, FASNC, Brett Sperry, MD, Saurabh Malhotra, MD, MPH, FASNC
3.    Questions and Panel Discussion – Faculty
 
Overall goal:
The overall goal of this educational initiative is to increase knowledge and awareness of the appropriate interpretation and reporting of Tc-99m PYP imaging and provide an update on the recent addendum to the expert consensus recommendations for Tc-99m PYP imaging. Imaging physicians need to understand how to perform, process, interpret, and report Tc-99m PYP imaging in appropriate patients and understand what can lead to false positive and false negative studies so that the right patients can be referred in a timely manner to amyloid experts for treatment and management. The initiative will
 
Learning Objectives:
  • Discuss recent addendum to Expert Consensus Recommendations
  • Ensure correct acquisition and processing of Tc-99m PYP imaging in work-up of cardiac amyloid patients
  • Apply a structured approach to interpret Tc99m-PYP images for ATTR cardiac amyloidosis
  • Describe the appropriate components of reporting Tc-99m PYP  studies using best practices and ASNC standardized reporting guidelines
 
Acknowledgement of Commercial Support
This activity is supported by a grant from Pfizer.